Erfa Canada Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 0
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 26
Notices of Compliance
Newest first.
- NORLUTATEAugust 31, 2010 · NOC 11697 · Supplement to a New Drug Submission (SNDS)
- ATARAXSeptember 14, 2005 · NOC 7373 · New Drug Submission (NDS)
- CELONTINSeptember 14, 2005 · NOC 7375 · New Drug Submission (NDS)
- MINIPRESSAugust 22, 2005 · NOC 7307 · New Drug Submission (NDS)
- CHLOROMYCETIN SUCCINATEAugust 19, 2005 · NOC 7296 · New Drug Submission (NDS)
- SINEQUANAugust 18, 2005 · NOC 7298 · New Drug Submission (NDS)
- NAVANEAugust 18, 2005 · NOC 7299 · New Drug Submission (NDS)
- NORLUTATEAugust 18, 2005 · NOC 7300 · New Drug Submission (NDS)
- ATARAX IM; ATARAX SYRUPAugust 17, 2005 · NOC 7290 · New Drug Submission (NDS)
- AMSA PDAugust 17, 2005 · NOC 7291 · New Drug Submission (NDS)
- MANDELAMINEAugust 17, 2005 · NOC 7292 · New Drug Submission (NDS)
- CHOLEDYL EXPECTORANT ELIXIRJuly 19, 2005 · NOC 7249 · New Drug Submission (NDS)
- CEREBYXJuly 12, 2005 · NOC 7233 · New Drug Submission (NDS)
- CHOLEDYL ELIXIRJuly 12, 2005 · NOC 7234 · New Drug Submission (NDS)
- CHOLEDYL SAJuly 12, 2005 · NOC 7235 · New Drug Submission (NDS)
- KETALARJuly 12, 2005 · NOC 7236 · New Drug Submission (NDS)
- LITHANEJuly 12, 2005 · NOC 7237 · New Drug Submission (NDS)
- NARDILJuly 12, 2005 · NOC 7238 · New Drug Submission (NDS)
- PONSTANJuly 12, 2005 · NOC 7240 · New Drug Submission (NDS)
- PROCAN SRJuly 12, 2005 · NOC 7241 · New Drug Submission (NDS)
- CERUBIDINEDecember 10, 2002 · NOC 410 · New Drug Submission (NDS)
- PARSITANNovember 29, 2002 · NOC 456 · New Drug Submission (NDS)
- ARLIDINNovember 29, 2002 · NOC 705 · New Drug Submission (NDS)
- MAJEPTILNovember 29, 2002 · NOC 800 · New Drug Submission (NDS)
- NEULEPTILNovember 28, 2002 · NOC 735 · New Drug Submission (NDS)
- PANECTYLNovember 28, 2002 · NOC 802 · New Drug Submission (NDS)